These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21541616)

  • 1. Allele loss of tumour suppressor genes on chromosome 17 in human testicular germ cell tumours.
    Vanderlooij M; Eid H; Bak M; Bodrogi I; Olah E
    Int J Oncol; 1996 Nov; 9(5):1087-90. PubMed ID: 21541616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours.
    Rothe M; Albers P; Wernert N
    J Pathol; 1999 Aug; 188(4):389-94. PubMed ID: 10440749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic Losses from Chromosome 17 in Human Osteosarcomas.
    Sztán M; Pápai Z; Szendrôi M; Looij M; Oláh E
    Pathol Oncol Res; 1997; 3(2):115-120. PubMed ID: 11173637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model.
    Faulkner SW; Leigh DA; Oosterhuis JW; Roelofs H; Looijenga LH; Friedlander ML
    Br J Cancer; 2000 Sep; 83(6):729-36. PubMed ID: 10952776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
    Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
    Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.
    Jongsma AP; Piek JM; Zweemer RP; Verheijen RH; Klein Gebbinck JW; van Kamp GJ; Jacobs IJ; Shaw P; van Diest PJ; Kenemans P
    Mol Pathol; 2002 Oct; 55(5):305-9. PubMed ID: 12354934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity of tumor suppressor genes in testis cancer.
    Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D
    Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
    Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
    Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer.
    Dunn J; Garde J; Dolan K; Gosney JR; Sutton R; Meltzer SJ; Field JK
    Oncogene; 1999 Jan; 18(4):987-93. PubMed ID: 10023674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.
    Staff S; Isola JJ; Johannsson O; Borg A; Tanner MM
    Br J Cancer; 2001 Oct; 85(8):1201-5. PubMed ID: 11710835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
    Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
    Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.